Blue Water Acquisition II registered to offer 7.5 million units at $10 each. A unit consists of one share and one-half of a warrant.
The new SPAC is focused on healthcare or healthcare related industries in the United States and Europe, the life sciences and pharmaceutical services sectors in particular.
Chairman and CEO Joseph Hernandez, who began his career at Merck, has since founded or led eight entrepreneurial companies in healthcare and pharmaceuticals.
Maxim is sole book-running manager. The underwriters have an option to purchase up to 1.125 million units to cover any over allotments.
The SPAC has applied to list on the Nasdaq under BWTRU. Read more.
